|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 3190127 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17159253.8 |
| Date of filing the European patent application | 2011-12-12 | |
| (97) | Date of publication of the European application | 2017-07-12 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 1060428 | 2010-12-13 | FR |
| (72) |
FOURNIER, Nathalie, FR
DE ROMEUF, Christophe, FR
|
| (73) |
Laboratoire Franēais du Fractionnement et des Biotechnologies,
ZA de Courtaboeuf 3, avenue des Tropiques, 91940 Les Ulis,
FR
|
| (54) | UTILISATION D`UN ANTICORPS DIRIGE CONTRE BDCA-2 POUR TRAITER DES MALADIES AUTO-IMMUNES OU INFLAMMATOIRES |
| USE OF AN ANTIBODY DIRECTED AGAINST BDCA-2 FOR THE TREATMENT OF AUTOIMMUNE OR INFLAMMATORY DISORDERS |